Point72 Hong Kong’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-172
Closed -$38K 1977
2022
Q2
$38K Buy
+172
New +$57.6K ﹤0.01% 1428
2021
Q4
Sell
-42
Closed -$35K 1945
2021
Q3
$35K Buy
42
+17
+68% +$17.2K ﹤0.01% 1602
2021
Q2
$32K Sell
25
-49
-66% -$55.3K ﹤0.01% 1558
2021
Q1
$81K Buy
74
+70
+1,750% +$92.4K ﹤0.01% 1195
2020
Q4
$6K Sell
4
-26
-87% -$27.7K ﹤0.01% 1576
2020
Q3
$21K Buy
+30
New +$21.8K ﹤0.01% 859
2020
Q2
Sell
-17
Closed -$6K 1156
2020
Q1
$6K Buy
+17
New +$12K ﹤0.01% 756
2019
Q4
Sell
-3
Closed -$1K 1175
2019
Q3
$1K Buy
+3
New +$962 ﹤0.01% 894
2019
Q1
Sell
-4
Closed 1045
2018
Q4
$0 Buy
+4
New +$674 ﹤0.01% 922
2018
Q2
Sell
-9
Closed -$1K 913
2018
Q1
$1K Buy
+9
New +$1.52K ﹤0.01% 820

Other funds holding CDLX

Point72 Hong Kong's CDLX Position: Q3 2022 in Review

Point72 Hong Kong sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 172 shares — an estimated $38K sold.

Point72 Hong Kong first reported a position in CDLX in Q1 2018 and held it in 10 quarters. The position peaked at $81K in Q1 2021. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

  • Point72 Hong Kong reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 172 Cardlytics shares in Q3 2022, an estimated $38K.
  • Point72 Hong Kong first reported a position in Cardlytics in Q1 2018 and held it in 10 quarters.
  • Point72 Hong Kong's Cardlytics position peaked at $81K in Q1 2021.
  • 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.